Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-Pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-Pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

CFDA Issues Guidance on Quality Control, Product Inspection

  • Post author:Sam
  • Post published:February 10, 2017
  • Post category:The GMP Letter

The China Food and Drug Administration (CFDA) has issued new guidance on quality control, finished product inspection, and other procedures for medical devices Source: The GMP Letter

Continue ReadingCFDA Issues Guidance on Quality Control, Product Inspection

FDA, DHS Warn of Cyber Vulnerabilities in St. Jude Cardiac Devices

  • Post author:Sam
  • Post published:February 10, 2017
  • Post category:The GMP Letter

The FDA and the Department of Homeland Security have flagged cybersecurity weaknesses in some St. Jude Medical implantable cardiac devices used with the company’s Merlin@home transmitters. Source: The GMP Letter

Continue ReadingFDA, DHS Warn of Cyber Vulnerabilities in St. Jude Cardiac Devices

Precision Interconnect Cited for Poor Documentation

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Precision Interconnect was hit with a Form 483 for poor corrective and preventive action (CAPA) procedures and failing to ensure that products conformed to requirements. Source: The GMP Letter

Continue ReadingPrecision Interconnect Cited for Poor Documentation

Lack of Corrective Action Procedures Earn Hansen Ophthalmic Form 483

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Hansen Ophthalmic Development Lab, Inc., received a Form 483 for not establishing procedures for corrective and preventive action, and for not maintaining a complete device history record. Source: The GMP…

Continue ReadingLack of Corrective Action Procedures Earn Hansen Ophthalmic Form 483

Panoramic Corp. Gets Form 483 for Reporting Failures

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Panoramic Corp. received a Form 483 for not reporting a correction and removal to the FDA and failing to submit medical device reports (MDRs). Source: The GMP Letter

Continue ReadingPanoramic Corp. Gets Form 483 for Reporting Failures

Inservco Inc. Receives Form 483 Citing Procedures, Device History

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Inservco Inc. received a Form 483 for not establishing a complaint handling procedure, failing to properly maintain device history records, and other violations. Source: The GMP Letter

Continue ReadingInservco Inc. Receives Form 483 Citing Procedures, Device History

White Square Chemical Gets Form 483 for Poor Procedures

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

White Square Chemical failed to establish a design history file, complete a risk analysis, and committed other violations, according to investigators who handed the company a Form 483. Source: The…

Continue ReadingWhite Square Chemical Gets Form 483 for Poor Procedures

CDRH Releases List of Guidance Documents Expected for 2017

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

CDRH last week released a list of final and draft guidances it intends to issue in fiscal year 2017. Source: The GMP Letter

Continue ReadingCDRH Releases List of Guidance Documents Expected for 2017

Hong Kong Issues Warnings for Pacing Leads, Stents, Ventilators

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

Hong Kong’s Department of Heath issued safety warnings for Boston Scientific Ingevity MRI endocardial pacing leads and Percuflex Urinary Diversion stents, Draeger Medical GmbH Oxylog 3000 and Oxylog 3000plus ventilators,…

Continue ReadingHong Kong Issues Warnings for Pacing Leads, Stents, Ventilators

United Contact Lens Cited for Product Testing, Procedures

  • Post author:Sam
  • Post published:January 18, 2017
  • Post category:The GMP Letter

United Contact Lens received a warning letter for failing to test finished products and establish written customer complaint procedures. Source: The GMP Letter

Continue ReadingUnited Contact Lens Cited for Product Testing, Procedures
  • Go to the previous page
  • 1
  • …
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.